The Role of Benralizumab in Eosinophilic Immune Dysfunctions: A Case Report-Based Literature Review
In the past years, the knowledge of eosinophils playing a primary pathophysiologic role in several associated conditions has led to the development of biologics targeting therapies aiming at normalizing the immune response, reducing chronic inflammation, and preventing tissue damage. To better illus...
Saved in:
| Main Authors: | Margarida Gomes, Ana Mendes, Filipa Ferreira, Joana Branco, Fernanda S. Tonin, M. Elisa Pedro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2023/8832242 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Benralizumab in Reducing FeNO in Severe Eosinophilic Asthma: The Role of CRSwNP
by: Garcia-Rivero JL, et al.
Published: (2025-05-01) -
Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-08-01) -
Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study
by: Stolz D, et al.
Published: (2024-12-01) -
Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report
by: Daiki Nagira, et al.
Published: (2025-05-01) -
Out of Breath, out of Options: Benralizumab as a Last Hope in ICU‐Treated Near‐Fatal Eosinophilic Asthma: A Case Series
by: Lennart Conemans, et al.
Published: (2025-03-01)